News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Scil Proteins GmbH Signs Licensing and Pre Manufacturing Agreement with Anabasis/Dompé for Eye Indications



6/30/2011 9:33:41 AM

HALLE, Germany--(BUSINESS WIRE)--Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma. Under the terms of this agreement Scil Proteins will license the microbial based manufacturing process for recombinant human Nerve Growth Factor (rhNGF) to Anabasis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES